available to support a sustainable effort to track SBIR/STTR outcomes. This is a critical and long-term need.”48
More specifically, as NIDA noted, “More time should be spent following up on grants near their end and after they no longer received NIH funding. We know little about Phase III and whether or not it actually occurs. Most time is spent funding the grant and administering it, but little or no time is spent on follow-up and evaluation.”49
Currently, the NIH SBIR/STTR Program Office must seek one-time funding for any significant assessment activity; this largely precludes longitudinal approaches needed for effective use of evaluation and assessment.